Ann Arbor-based Michigan Medicine is projected to finish fiscal 2025 with an operating income of $233.5 million (2.7% operating margin).
The projected results for the year ending June 30 were presented to the University of Michigan Board of Regents June 12, according to a news release.
The 11-hospital system is projected to end the year with total operating revenue of $8.5 billion.
The system exceeded its expected financial performance for the year due to greater-than-expected patient volumes across its statewide network, according to the release. The system had planned for a 1.7% operating margin in 2025.
“Our success in fiscal 2025 was rooted in our BASE + Growth priorities: Belonging, Access, Safety, Experience and Growth,” Michigan Medicine CEO David Miller, MD, said in the release. “Our team’s commitment and dedication to those goals results in a successful, integrated, cost-effective and high-quality health care system.”
The Regents approved the health system’s budget for the fiscal year that begins July 1. Michigan Medicine is aiming for a 1.7% operating margin in 2026.
